WASHINGTON — Merck on Tuesday sued to stop the federal government from implementing a new Medicare drug price negotiation program.
Merck called the negotiation process that Democrats designed in a law last August “a sham,” arguing that the federal government “dictates” prices.
The company argues in the lawsuit that the Inflation Reduction Act is unconstitutional for two reasons. The first is because the law allows the government to force drugmakers to sell their property without “just compensation,” which the company argues violates the Fifth Amendment.
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.